Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (279)
- COVID-19 (163)
- Safety monitoring and information (104)
- Legislation (96)
- Compliance and enforcement (72)
- Manufacturing (57)
- Vaping hub (55)
- Labelling and packaging (38)
- Import and export (29)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (18)
- Weight loss products (15)
- Shortages and supply disruptions (13)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1273 result(s) found, displaying 1026 to 1050
-
-
Regulatory decision noticesA new S41BD(3) instrument has been signed to declare that some nappy rash products are not to be medical devices for the purposes of the Act
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
-
Regulatory decision noticesNew requirements for listed medicines containing Andrographis paniculata
-
News articlesSome label warnings no longer required for medicines containing very low concentrations of menthol or methyl salicylate
-
Media releasesWe will closely consider the judgement including any further improvements that could enhance the regulatory system in Australia.
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Media releasesAcalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada
-
Media releasesThe TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance
-
Media releasesConsumer Healthcare Products Australia to handle all medicine advertising pre-approval applications
-
BlogFrom animals intestines to intrauterine devices, contraception has a fascinating history.
-
News articlesGeneral information for consumers on prescription opioids
-
-
Media releasesThe Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
BlogImportant information for women breast implants so you have all the information you need to make the right decisions about your health.
-
Media releasesThe Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne
-
Media releasesA warning to consumers about undergoing procedures using unapproved medical devices
-
BlogLearn about the evidence for medicinal cannabis, and how a medical doctor can organise medicinal cannabis access on behalf of appropriate patients.
-
Media releasesChanges are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements
-
BlogWhat does Neo from the Matrix need to know before choosing a pill to take?
-
Regulatory decision noticesTherapeutic Goods (Declared Goods) Order 2019 consolidates and replaces several instruments
-
Regulatory decision noticesJapan has recently been added to the list of Foreign Countries and Jurisdictions determined to be comparable overseas regulators
-
News articlesConsidering microneedling? Make sure you do your research first